Skip to Main Content

Paper Details

Serum testosterone and prostate cancer in men with germline <i>BRCA1/2</i> pathogenic variants.
BJUI Compass
3
2023
Author NameAffiliation
Elizabeth BancroftOncogenetics Team The Institute of Cancer Research London UK.
Elizabeth BancroftAcademic Urology Unit Royal Marsden NHS Foundation Trust London UK.
Sarah ThomasOncogenetics Team The Institute of Cancer Research London UK.
Tokhir DadaevOncogenetics Team The Institute of Cancer Research London UK.
Daniel LeongamornlertOncogenetics Team The Institute of Cancer Research London UK.
Cezary CybulskiInternational Hereditary Cancer Center, Department of Genetics and Pathology Pomeranian Medical University in Szczecin Szczecin Poland.
Zsofia Kote-JaraiOncogenetics Team The Institute of Cancer Research London UK.
Rosalind A EelesOncogenetics Team The Institute of Cancer Research London UK.
Rosalind A EelesAcademic Urology Unit Royal Marsden NHS Foundation Trust London UK.
  • 1 - 9

Datasets

Release 1.2